PMID- 28105491 OWN - NLM STAT- MEDLINE DCOM- 20170828 LR - 20181113 IS - 1420-9071 (Electronic) IS - 1420-682X (Linking) VI - 74 IP - 12 DP - 2017 Jun TI - The multi-faceted role of retinoid X receptor in bone remodeling. PG - 2135-2149 LID - 10.1007/s00018-017-2458-4 [doi] AB - Retinoid X receptors (RXRs) form a unique subclass within the nuclear receptor (NR) superfamily of ligand-dependent transcription factors. RXRs are obligatory partners for a number of other NRs, placing RXRs in a coordinating role at the crossroads of multiple signaling pathways. In addition, RXRs can function as self-sufficient homodimers. Recent advances have revealed RXRs as novel regulators of osteoclastogenesis and bone remodeling. This review outlines the versatility of RXR action in the control of transcription of bone-forming osteoblasts and bone-resorbing osteoclasts, both through heterodimerization with other NRs and through RXR homodimerization. RXR signaling is currently a major therapeutic target and, therefore, knowledge of how RXR signaling affects bone remodeling creates enormous potential for the translation of basic research findings into successful clinical therapies to increase bone mass and improve bone quality. FAU - Menendez-Gutierrez, Maria P AU - Menendez-Gutierrez MP AD - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernandez Almagro, 3, 28029, Madrid, Spain. FAU - Ricote, Mercedes AU - Ricote M AUID- ORCID: 0000-0002-8090-8902 AD - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernandez Almagro, 3, 28029, Madrid, Spain. mricote@cnic.es. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20170119 PL - Switzerland TA - Cell Mol Life Sci JT - Cellular and molecular life sciences : CMLS JID - 9705402 RN - 0 (Retinoid X Receptors) SB - IM MH - Animals MH - *Bone Remodeling MH - Bone Resorption/pathology MH - Humans MH - Models, Biological MH - Protein Multimerization MH - Retinoid X Receptors/*metabolism OTO - NOTNLM OT - 9-cis retinoic acid OT - Agonists OT - Antagonists OT - Bexarotene OT - Bone resorption OT - Heterodimers OT - Homodimers OT - MAFB OT - Osteoporosis OT - Permissive OT - Rexinoids OT - Skeleton EDAT- 2017/01/21 06:00 MHDA- 2017/08/29 06:00 CRDT- 2017/01/21 06:00 PHST- 2016/09/30 00:00 [received] PHST- 2017/01/04 00:00 [accepted] PHST- 2016/12/20 00:00 [revised] PHST- 2017/01/21 06:00 [pubmed] PHST- 2017/08/29 06:00 [medline] PHST- 2017/01/21 06:00 [entrez] AID - 10.1007/s00018-017-2458-4 [pii] AID - 10.1007/s00018-017-2458-4 [doi] PST - ppublish SO - Cell Mol Life Sci. 2017 Jun;74(12):2135-2149. doi: 10.1007/s00018-017-2458-4. Epub 2017 Jan 19.